ESR1 and breast carcinoma: The association of hepatocyte growth factor (HGF) with breast cancer was stronger in Estrogen Receptor (ER)-negative patients, while CASP8, CXCL11, MMP7, and C–C motif chemokine 4 (CCL4) were associated with ER-positive breast cancer (Fig. 4).